| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 11/04/1992 | CA2067839A1 Use of estrogens or antiandrogens or estrogens in combination with antiandrogens for reversal of male sexual phenotype in poultry |
| 11/03/1992 | CA2067520A1 Treatment of mastitis |
| 11/02/1992 | CA2067663A1 Pyrazine derivatives |
| 10/29/1992 | WO1992018519A1 Novel cytarabine derivatives, their production and use |
| 10/29/1992 | WO1992018461A1 Ethanolamine derivatives with anti-pollakiuria activity |
| 10/29/1992 | WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method |
| 10/29/1992 | DE4200954A1 New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc. |
| 10/28/1992 | EP0511072A1 2-Aminopyrimidin-4-carboxamid derivatives, their preparation and their therapeutical use |
| 10/28/1992 | EP0511003A1 Superactive GRF analogs |
| 10/28/1992 | EP0510748A1 Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases |
| 10/28/1992 | EP0510398A2 N-Imidazolyl derivatives of substituted indole |
| 10/28/1992 | EP0441832A4 Composition and treatment with biologically active peptides and certain anions |
| 10/27/1992 | CA2067304A1 Superactive grf analogs |
| 10/27/1992 | CA1309409C Dibenz-oxepin and -thiepin derivatives |
| 10/25/1992 | WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY |
| 10/25/1992 | CA2106764A1 Ó-substituted polypeptides having therapeutic activity |
| 10/25/1992 | CA2066960A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy |
| 10/25/1992 | CA2066938A1 N-imidazolyl derivatives of substituted indole |
| 10/21/1992 | EP0509762A1 Indole and dihydroquinoline potassium channel openers |
| 10/21/1992 | EP0509259A1 The use of aminosteroids for the preparation of pharmaceutical compositions |
| 10/21/1992 | EP0509027A1 A process to correct and optimize the composition of a feed. |
| 10/20/1992 | US5157140 Esters of myo-inositol phosphate |
| 10/20/1992 | US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA |
| 10/20/1992 | CA1309088C 17.beta.-(CYCLOPROPYLOXY)ANDROST-5-EN-3.beta.-OL AND RELATED COMPOUNDS USEFUL ASC -- -LYASE INHIBITORS |
| 10/20/1992 | CA1309019C Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| 10/16/1992 | CA2065499A1 Indole and dihydroquinoline potassium channel openers |
| 10/15/1992 | WO1992017575A1 Novel leucine aminopeptidase |
| 10/15/1992 | WO1992017190A1 Dry starch-iodine pharmaceutical formulations |
| 10/15/1992 | DE4111679A1 Neue cytarabin-derivate, ihre herstellung und verwendung New cytarabine derivatives, their production and use |
| 10/14/1992 | EP0348429B1 Liver lactogenic factor |
| 10/14/1992 | CN1065270A Process for preparation of enantiomerically pure thienopyran derivatives |
| 10/13/1992 | US5155259 Aldose reductase inhibitor |
| 10/13/1992 | CA1308721C Benzimidazol-2-one derivatives and their salts; process and intermediates for preparing the same; their use as drugs; compositions containing them |
| 10/11/1992 | CA2106857A1 Novel cytarabine derivatives, their production and use |
| 10/07/1992 | EP0506903A1 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist |
| 10/07/1992 | EP0493380A4 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
| 10/07/1992 | CN1065062A Quinoline-containing ketoacids as leukotriene antagonists |
| 10/01/1992 | WO1992017025A2 GnRH ANALOGS |
| 10/01/1992 | WO1992016620A1 Human follicle stimulating hormone receptor |
| 10/01/1992 | WO1992016552A1 1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity |
| 10/01/1992 | WO1992016517A1 Pharmaceutical xanthone derivatives |
| 10/01/1992 | WO1992016213A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 10/01/1992 | WO1992016201A1 Method for inactivating enveloped viruses and sperm |
| 09/30/1992 | EP0506384A1 Pharmaceutical composition for the treatment of urinary incontinence containing DL- or L-threo-3-(3,4-dihydroxyphenyl)serine |
| 09/30/1992 | EP0506363A1 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 09/30/1992 | EP0505954A1 N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity |
| 09/29/1992 | CA2064384A1 6-heterocyclic-4-amino-1,3,4,5- tetrahydrobenz [cd] indoles |
| 09/16/1992 | EP0503162A1 Azole derivatives, process for their preparation and their application |
| 09/15/1992 | US5147855 Modified vasoactive intestinal peptide |
| 09/15/1992 | CA1307537C N-naphthoylglycines as aldose reductase inhibitors |
| 09/15/1992 | CA1307526C Bcd tricyclic ergoline part-structure analogues |
| 09/09/1992 | EP0502550A1 Colominic acid and partial hydrolysis products of colominic acid for the preparation of medicaments for the treatment of hepatitis, nephritis and arthritis |
| 09/09/1992 | EP0502314A1 Benzimidazol, medicaments containing them and process for their preparation |
| 09/09/1992 | EP0305400B1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 09/09/1992 | EP0292517B1 Improvements in or relating to the use of epidermal growth factor |
| 09/09/1992 | CN1064269A 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 09/08/1992 | US5145851 Method for treating urinary obstruction |
| 09/08/1992 | CA2062370A1 Pharmaceutical preparation |
| 09/03/1992 | WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 09/02/1992 | EP0501870A1 New pharmaceutical compositions, particularly for the treatment of functional infections of the large intestines, and process for obtaining them |
| 09/02/1992 | EP0501705A1 Use of tomoxetine for the treatment of lower urinary tract disorders |
| 09/02/1992 | EP0501578A1 Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| 09/02/1992 | EP0501251A2 The enantiomer (+)-N-(2-ethoxyphenyl)-N',N'-(1,2,2-trimethylpropyl)-2-nitroethen-1,1-diamine, method for its preparation and its use |
| 09/02/1992 | EP0501056A1 Danazol containing compositions for the treatment of endometriosis |
| 09/02/1992 | EP0500807A1 Tissue moisturizing composition and method |
| 09/01/1992 | US5144059 Cardiovascular and kidney disorders |
| 09/01/1992 | US5143909 Treating androgen-dependent disorders |
| 08/26/1992 | EP0500409A1 4-Pyrimidinone derivatives, their preparation and their application in therapy |
| 08/26/1992 | EP0500360A1 Quinoline-containing ketoacids as leukotriene antagonists |
| 08/26/1992 | EP0500297A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | CN1063870A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 08/26/1992 | CN1063869A Nitrogenous bicyclic derivatives, their preparation process, intermediates obtained, their use as medicaments and pharomaceutical composition containing them |
| 08/21/1992 | CA2061456A1 4-pyrimidinone derivatives, their preparation and their application in therapy |
| 08/20/1992 | WO1992013855A1 (2-imidazolin-2-ylamino) tetrahydroquinolaxines and methods for using same |
| 08/19/1992 | EP0499544A2 Use of tetrahydropiridin-derivatives as inhibitors of angiogenesis |
| 08/19/1992 | EP0499444A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans |
| 08/19/1992 | EP0499348A1 Ovulation-inhibiting agent for hormonal contraception |
| 08/19/1992 | EP0499164A1 Injectable compositions to replace lubricating body fluids |
| 08/19/1992 | EP0305401B1 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| 08/19/1992 | EP0288478B1 Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 08/19/1992 | CN1063691A Amino acid derivatives process for preparation thereof and pharmaceutical composition comprising same |
| 08/19/1992 | CN1063685A Calcium uptake inhibitors |
| 08/18/1992 | US5140038 Thromboxane A2 antagonists |
| 08/18/1992 | US5139778 Antibiotic ge 2270 factors a1, a2, a3 and h |
| 08/18/1992 | CA1306432C Use of efomycins as performance promoters in animals, efomycins and theirpreparation |
| 08/17/1992 | WO1992014714A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 08/15/1992 | CA2061173A1 Compositions comprising tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 08/12/1992 | EP0498723A1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them |
| 08/12/1992 | EP0498722A1 Bicyclic nitrogen compounds, their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them |
| 08/12/1992 | EP0498721A1 N-substituted quinoline derivatives, process for their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them |
| 08/12/1992 | EP0498590A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
| 08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/12/1992 | CA2060940A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydro-naphthalenes and chromans |
| 08/11/1992 | US5137882 Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
| 08/11/1992 | US5137722 Extract and pharmaceutical composition for treatment of calcium oxalate stone disease |
| 08/10/1992 | WO1992013539A1 Ovulation-preventing agent for hormonal contraception |
| 08/08/1992 | CA2060843A1 N-substituted derivatives of quinoleine, process for their preparation, new intermediates obtaines, their application as drugs and pharmaceutical compositions containing them |
| 08/08/1992 | CA2060771A1 Nitrogenated bicyclic derivatives substitutes by a benzyl radical, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and pharmaceutical compositions containing them |